The

health care

sector closed the day up 0.1%.

ProPhase Labs Inc

(

PRPH

),

Cardium Therapeutics Inc

(

CXM

),

Galena Biopharma Inc

(

RXII

), and

Senesco Technologies Inc

(

SNT

) were all winners today within the health care sector with

Merck & Co Inc

(

MRK

) being today's featured health care winner. Merck & Co Inc rose 72 cents (2.3%) to $32.66 on average volume. Throughout the day, 19.3 million shares of Merck & Co Inc exchanged hands as compared to its average daily volume of 17.5 million shares.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. Merck & Co Inc has a market cap of $99 billion and is part of the

drugs

industry. The company has a P/E ratio of 34.6, above the average drugs industry P/E ratio of 34.2 and above the S&P 500 P/E ratio of 17.7. Shares are down 10.8% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Merck & Co as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front,

BioDelivery Sciences International Inc

(

BDSI

),

Aoxing Pharmaceutical Company Inc

(

AXN

),

NeurogesX Inc

(

NGSX

), and

Escalon Medical Corporation

(

ESMC

) were all losers within the health care sector with

Cardiome Pharma

(

CRME

) being today's health care sector Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null